Home - Gastroenterology Advisor
WEBThe Infectious Diseases Society of America has released updated guidance on the diagnosis and management of complicated intra-abdominal infections.
Clinician Insights on How to Manage Semaglutide-Induced …
WEBSep 8, 2023 · Two clinicians weigh in on the link between semaglutide and gastroparesis and how to help patients manage symptoms.
What We Know About Semaglutide Adverse Events and …
WEBSep 1, 2023 · Recent reports of severe semaglutide adverse events, such as gastroparesis, have raised concerns about the drug used for weight loss and type 2 diabetes.
FDA Limits Authorized Use of COVID-19 PrEP Therapy Pemgarda
WEB10 hours ago · The FDA has revised the EUA for Pemgarda (pemivibart), authorized for the preexposure prophylaxis of COVID-19.
Gastroparesis Awareness Month: Updated Guidelines to Treat …
WEBAug 19, 2022 · For the first time since 2013, the American College of Gastroenterology has released updated recommendations for managing gastroparesis.
Intestinal Ultrasound for IBD: Clinical Practice Update From the AGA
WEBAug 2, 2024 · A committee from the American Gastroenterological Association has outlined clinical best practices for incorporating intestinal ultrasound into IBD management.
2021 American College of Gastroenterology Guidelines: Upper ...
WEBJun 2, 2021 · The American College of Gastroenterology released clinical guidelines on upper gastrointestinal and ulcer bleeding using an evidence-based approach.
Tradipitant Relieves Nausea, Other Gastroparesis Symptoms
WEBTradipitant significantly improved nausea and other symptoms in patients with idiopathic and diabetic gastroparesis compared with placebo, according to study results presented at the American College of Gastroenterology (ACG) 2022 Annual Meeting, held from October 21 to 26, 2022, in Charlotte, North Carolina, and virtually.
Short-Acting GLP-1 RAs May Increase GERD, Barrett Esophagus …
WEBMay 12, 2023 · Short-acting, not long-acting, GLP-1 receptor agonists increase the risk for GERD and Barrett esophagus among patients with type 2 diabetes.
Novel Drug Tradipitant Effective, Safe for Treatment of Nausea in ...
WEBOct 29, 2021 · Tradipitant appears to be an effective and safe treatment option for gastroparesis symptoms, according to research presented at the American College of Gastroenterology (ACG) 2021 Annual Meeting, held from October 22 to 27, 2021, in Las Vegas, Nevada and virtually.